FdaApplication

NDA 213736

Back to search

Identifiers

Properties

PropertyValue
applicant_nameINCYTE CORP
application_typeNDA
approval_date2020-04-17

Products (3)

ProductActive ingredientStrengthDosage form
PEMAZYREPEMIGATINIB4.5MGTABLET;ORAL
PEMAZYREPEMIGATINIB13.5MGTABLET;ORAL
PEMAZYREPEMIGATINIB9MGTABLET;ORAL

3 products